Magnesium in the prophylaxis of migraine - A double-blind, placebo-controlled study

Cephalalgia

Volumn 16, Issue 6, 1996, Pages 436-440

  Pfaffenrath, V ^a,h   Wessely, P ^b   Meyer, C ^a   Isler, H R ^c   Evers, S ^d   Grotemeyer, K H ^e   Taneri, Z ^e   Soyka, D ^f   Gobel H ^f   Fischer, M ^g  

^a University of Vienna ^*

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e Clin for Psychosomatics and Neurol   (Switzerland)

^f UNIVERSITY OF KIEL   (Germany)

^g Medical Department of 3M Medica   (Germany)

^h NONE   (Germany)

Author keywords

Efficacy; Magnesium; Migraine prophylaxis; Safety; Tolerability

Indexed keywords

MAGNESIUM; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

EID: 10144226386     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1606436.x     Document Type: Article

References (28)

1. Wilkinson M, Pfaffenrath V, Schoenen J, Diener HC, Steiner T. Migraine and cluster headache - their management with sumatriptan. Cephalalgia 1495;15:337-57
2. Gross M. Current and future therapies for migraine. Exp Opin Invest Drugs 1995;4:(4):283-90
3. Swanson DR. Migraine and magnesium: eleven neglected connections. Persp Biol Med 1988;31:(4):526-57
4. Facchinetti F, Sances G, Borella P, Genazzam AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-310
5. Welch KMA, Levine SR, D'Andrea G, Schultz L, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo 31-phosphorus spectroscopy. Neurology 1989;39:538-41
6. Ramadan NM, Halvorson H, Vande-Linde A, Levine S, Helpern JA, Welch KMA. Low brain magnesium in migraine. Headache 1989;29:590-3
7. Schoenen J, Sianard-Gainko J, Lenaerts M. Blood magnesium levels in migraine. Cephalalgia 1991;11:97-9
8. Durlach J. Neurological manifestations of magnesium imbalance. Handbook Clin Neurol 1976;8:545-79
9. Jain AC, Sethi NC, Balbar PK. A clinical electroencephalographic and trace element study with special reference to zinc, copper and magnesium in serum and cerebrospinal fluid (CSF) in cases of migraine. J Neurol 1985;232:161
10. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V. Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia 1992;12:21-8
11. 2+ ratio. Headache 1993;33:135-8
12. Baudouin-Legros M, Dard B, Guichency P. Hyperreactivity of platelets from spontaneously hypertensive rats. Role of external magnesium. Hypertension 1986;8:694-9
13. Goldstein S, Zsoter TI. The effect of magnesium on the response of smooth muscle to 5hydroxytryptamine. Br Pharmacol 1978;62:507-14
14. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987;9:379-83
15. Van Harreveld A, Ochs S. Electrical and vascular concomitant of spreading depression. Am J Physiol 1957;189:(1):159-66
16. Mody I, Lambert JDC, Heinemann V. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987;57: 869-88
17. Van Harreveld A, Fifkova E. Mechanisms involved in spreading depression. J Neurobiol 1973;4:375-87
18. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52
19. Woods KP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-92
20. Weaver K. Magnesium and migraine. Letter to the editor. Headache 1990;30:168
21. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96
22. International Headache Society Committee on Clinical Trials on Migraine. Guidelines for controlled trials for drugs in migraine. Cephalalgia 1991;11:1-12
23. Gerber WD, Schellenberg R, Thom M, Haufe C, Bolsche F, Wedekind W, et al. Cyclandelate versus propranolol in the prophylaxis of migraine: a double-blind placebo-controlled study. Funct Neurol 1995;10:(1):27-35
24. Kjaersgaard Rasmussen MJ, Holt Larsen B, Borg L, Soelberg Sorensen P, Hansen PE. Tolfenamic acid versus propranolol in the prophylactic treatment of migraine. Acta Neurol Scand 1994;89:(6):446-50
25. Ziegler DK, Hurwitz, A, Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects. Arch Neurol 1993;50(8):825-30
26. al-Qassab HK, Findley LJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. Cephalalgia 1993;13:(2):128-31
27. Gawel MJ Kreeft J, Nelson RF, Simard D, Arnott WS. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine. Can J Neurol Sci 1992;19: (3):340-5
28. Gerber WD, Diener HC, Scholz E, Niederberger U. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia 1991;11:(1):37-45